Pacific Biosciences
PACB
#6557
Rank
$0.72 B
Marketcap
$2.39
Share price
-5.16%
Change (1 day)
17.73%
Change (1 year)

Pacific Biosciences (PACB) - Cash on Hand

Cash on Hand as of September 2025 : $0.29 Billion USD

According to Pacific Biosciences 's latest financial reports the company has $0.29 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Pacific Biosciences - Cash on Hand chart (from 2009 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31$0.38 B-38.24%
2023-12-31$0.63 B-18.24%
2022-12-31$0.77 B-26.05%
2021-12-31$1.04 B227.59%
2020-12-31$0.31 B549.33%
2019-12-31$49.09 M-52.03%
2018-12-31$0.10 B62.8%
2017-12-31$62.87 M-12.65%
2016-12-31$71.97 M-12.51%
2015-12-31$82.27 M-18.82%
2014-12-31$0.10 B-9.94%
2013-12-31$0.11 B11.88%
2012-12-31$0.10 B-43.31%
2011-12-31$0.17 B-37.45%
2010-12-31$0.28 B205.9%
2009-12-31$92.73 M-12.56%
2008-12-31$0.10 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Illumina
ILMN
$1.27 B 327.92%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoString Technologies
NSTG
$97.1 M-67.49%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
$13.50 B 4,423.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Luminex
LMNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
$3.54 B 1,087.33%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
$2.46 B 724.08%๐Ÿ‡บ๐Ÿ‡ธ USA